SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000891092-04-004444
Filing Date
2004-09-15
Accepted
2004-09-15 17:04:55
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 e19065_s3.txt S-3 108737
2 OPINION OF COUNSEL e19065ex5_1.txt EX-5.1 3649
3 CONSENT OF INDEPENDENT REGISTERED ACCOUNTANTS e19065ex23_1.txt EX-23.1 752
4 CONSENT OF IND. REGISTERED PUBLIC ACCOUNTING FIRM e19065ex23_2.txt EX-23.2 976
  Complete submission text file 0000891092-04-004444.txt   116069
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-119017 | Film No.: 041032208
SIC: 2836 Biological Products, (No Diagnostic Substances)